Nephrology
2 drugs are in development for Chronic Kidney Disease.
- Companies
- 2
- Clinical trials
- 48
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Chronic Kidney Disease pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Preclinical(1)
| Drug | Company |
|---|---|
| ergod2 | ENTIA BIOSCIENCES, INC. (ERGO) |
Phase 4(1)
| Drug | Company |
|---|---|
| insulin glargine | ELI LILLY & Co (LLY) |
About this indication
Chronic Kidney Disease context
Nephrology·MeSH: Renal Insufficiency, Chronic (D051436)
Narrower concept of MeSH descriptor Renal Insufficiency, Chronic
Prevalence
15000.0 / 100K
Incidence
500.0 / 100K/yr
Frequently asked questions
How many drugs are in development for Chronic Kidney Disease?
BioSniper tracks 2 drugs in development for Chronic Kidney Disease across 2 companies.
How many clinical trials target Chronic Kidney Disease?
There are 48 clinical trials targeting Chronic Kidney Disease tracked by BioSniper.
What is the prevalence of Chronic Kidney Disease?
The estimated prevalence of Chronic Kidney Disease is approximately 15000.0 per 100,000 population.